BCA-356

N/A

Report date: 2025/01/26 15:01:22

Base Information

Drug NameBCA-356
Drug Alias NameBCA-356
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin-12 receptor stimulantsCarbonic anhydrase IX modulators
TargetsCarbonic anhydrase IXInterleukin-12 receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBicara Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBicara Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A